On this basis, this receptor in addition to a conditioning chemotherapy regimen of Cy and Nab-paclitaxel in order to eradicate stroma in other EGFR-positive solid tumors including cholangiocarcinoma (CCA) and pancreatic cancer (PC) are being tested. The gene discussed is EGFR; the disease is cholangiocarcinoma.